349 related articles for article (PubMed ID: 19608079)
1. Histologic grading of invasive lobular carcinoma: does use of a 2-tiered nuclear grading system improve interobserver variability?
Adams AL; Chhieng DC; Bell WC; Winokur T; Hameed O
Ann Diagn Pathol; 2009 Aug; 13(4):223-5. PubMed ID: 19608079
[TBL] [Abstract][Full Text] [Related]
2. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.
Scholten AN; Smit VT; Beerman H; van Putten WL; Creutzberg CL
Cancer; 2004 Feb; 100(4):764-72. PubMed ID: 14770433
[TBL] [Abstract][Full Text] [Related]
4. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
[TBL] [Abstract][Full Text] [Related]
5. A newly proposed semi-automated method of grading invasive lobular carcinoma: a unifying concept and correlation with prognostic markers and patient survival.
Stevens E; Kimler BF; Davis MK; Fan F; Thomas P; Wang XY; Damjanov I; Tawfik OW
Ann Clin Lab Sci; 2009; 39(1):25-31. PubMed ID: 19201737
[TBL] [Abstract][Full Text] [Related]
6. Interobserver agreement of the Nottingham histologic grading scheme for infiltrating duct carcinoma breast.
Sikka M; Agarwal S; Bhatia A
Indian J Cancer; 1999; 36(2-4):149-53. PubMed ID: 10921219
[TBL] [Abstract][Full Text] [Related]
7. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.
Malpica A; Deavers MT; Tornos C; Kurman RJ; Soslow R; Seidman JD; Munsell MF; Gaertner E; Frishberg D; Silva EG
Am J Surg Pathol; 2007 Aug; 31(8):1168-74. PubMed ID: 17667538
[TBL] [Abstract][Full Text] [Related]
8. Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma.
Bektas S; Bahadir B; Kandemir NO; Barut F; Gul AE; Ozdamar SO
Kaohsiung J Med Sci; 2009 Nov; 25(11):596-600. PubMed ID: 19858038
[TBL] [Abstract][Full Text] [Related]
9. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
[TBL] [Abstract][Full Text] [Related]
10. Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group.
Yamamoto S; Kasajima A; Takano M; Yaegashi N; Fujiwara H; Kuzuya K; Kigawa J; Tsuda H; Kurachi H; Kikuchi Y; Sugiyama T; Tsuda H; Moriya T
Int J Gynecol Pathol; 2011 Mar; 30(2):129-38. PubMed ID: 21293288
[TBL] [Abstract][Full Text] [Related]
11. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
12. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system.
Shimizu Y; Kamoi S; Amada S; Hasumi K; Akiyama F; Silverberg SG
Gynecol Oncol; 1998 Jul; 70(1):2-12. PubMed ID: 9698465
[TBL] [Abstract][Full Text] [Related]
13. Invasive lobular breast cancer. Prognostic significance of histological malignancy grading.
Talman ML; Jensen MB; Rank F
Acta Oncol; 2007; 46(6):803-9. PubMed ID: 17653904
[TBL] [Abstract][Full Text] [Related]
14. Cytopathological grading, as a predictor of histopathological grade, in ductal carcinoma (NOS) of breast, on air-dried Diff-Quik smears.
Khan MZ; Haleem A; Al Hassani H; Kfoury H
Diagn Cytopathol; 2003 Oct; 29(4):185-93. PubMed ID: 14506669
[TBL] [Abstract][Full Text] [Related]
15. Nuclear grading of breast carcinoma by image analysis. Classification by multivariate and neural network analysis.
Dawson AE; Austin RE; Weinberg DS
Am J Clin Pathol; 1991 Apr; 95(4 Suppl 1):S29-37. PubMed ID: 2008882
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and biomarker analysis of invasive pleomorphic lobular carcinoma as compared with invasive classic lobular carcinoma: an experience in our institution and review of the literature.
Jacobs M; Fan F; Tawfik O
Ann Diagn Pathol; 2012 Jun; 16(3):185-9. PubMed ID: 22197540
[TBL] [Abstract][Full Text] [Related]
17. Classification and grading of invasive breast carcinoma.
Elston CW
Verh Dtsch Ges Pathol; 2005; 89():35-44. PubMed ID: 18035670
[TBL] [Abstract][Full Text] [Related]
18. Cytologic diagnosis of invasive lobular carcinoma: factors associated with negative and equivocal diagnoses.
Hwang S; Ioffe O; Lee I; Waisman J; Cangiarella J; Simsir A
Diagn Cytopathol; 2004 Aug; 31(2):87-93. PubMed ID: 15282719
[TBL] [Abstract][Full Text] [Related]
19. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
Bharat A; Gao F; Margenthaler JA
Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
